UNSPSC 51294502: Altanserin

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51294502

Definition

This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 5015H744JQ chemically known as 3-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1h,3h)-quinazolinedione but generally known as altanserin, which bears US NIH Compound Identifier 3033677. European Medicines Agency schedules Altanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05375MIG.

Read the full definition

The term ALTANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations schedule altanserin under HS 29335995 and SITC 51576. As of Q4 2014, ALTANSERIN remains the US FDA Preferred Term for this commodity. Altanserin bears US NLM identifiers UMLS ID C0102811 and NCI Concept Code C77258. SMILES: C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=S.

About UNSPSC 51294502

UNSPSC 51294502 Altanserin, a Commodity code, nominally names a single pharmaceutical product, but the recent state and local activity under this code tag shows a mismatch: Seminole County, Florida's posted solicitation concerns naloxone and drug deactivation systems, not altanserin. State and local procurement offices occasionally misalign UNSPSC taxonomy with actual scope of work, and this code shows little activity directly tied to the altanserin product line itself. The single recent opportunity in the dataset reflects pharmaceutical supply procurement more broadly — an IFB for health and safety products supporting community health initiatives — rather than altanserin-specific sourcing. Without additional opportunities tagged to this code in the source material, the actual volume of state and local demand for altanserin as a distinct commodity remains unclear.

Seminole County issued IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement is structured as a competitive IFB with a two-year initial term and one-year renewal option; vendors must include all shipping and delivery costs in their bid, provide unit pricing for each line item, and comply with drug-free workplace certification, E-Verify, and federal compliance requirements including Clean Air Act and Federal Water Pollution Control Act adherence. The contract includes a three-month probationary termination-at-will period and is potentially FEMA-funded. Beyond this single Seminole County opportunity, the source does not identify other recent state or local solicitations under this code, limiting visibility into the geographic or issuing-body mix for altanserin or closely related pharmaceutical commodities.

Quick answers

What is UNSPSC 51294502?

UNSPSC 51294502 is Altanserin, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51294502?

UNSPSC 51294502 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51294502

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code